References in the content below refer to the PBMEF Guide.
Definitions
Number of patients with resistance to both isoniazid and rifampicin (DR-TB), among new bacteriologically confirmed pulmonary TB patients with available drug- susceptibility testing results for isoniazid and rifampicin.
Numerator
Number of patients with resistance to both isoniazid and rifampicin (DR-TB), among new bacteriologically confirmed pulmonary TB patients with available drug-susceptibility testing results for isoniazid and rifampicin. WHO database: mdr_new
Denominator
N/A
Ref # |
(Previously DT-24) |
Tier Level |
Extended Indicator
|
Data Type |
Integer
|
Disaggregations |
N/A |
There are no related indicators for this indicator.